NPI: 1851367031 · WASHINGTON, DC 20020 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/27/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/27/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 38,947 | $558K |
| 2019 | 35,866 | $508K |
| 2020 | 32,421 | $534K |
| 2021 | 32,814 | $596K |
| 2022 | 33,146 | $839K |
| 2023 | 16,157 | $592K |
| 2024 | 7,261 | $574K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 66,084 | 5,215 | $3.75M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 50,134 | 3,042 | $350K |
| J1756 | Injection, iron sucrose, 1 mg | 14,330 | 3,284 | $50K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,178 | 475 | $29K |
| J1270 | Injection, doxercalciferol, 1 mcg | 35,322 | 3,055 | $16K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 663 | 202 | $2K |
| J1644 | Injection, heparin sodium, per 1000 units | 1,679 | 229 | $2K |
| 83970 | 2,653 | 2,068 | $1K | |
| 90732 | 33 | 29 | $853.61 | |
| 90674 | 86 | 76 | $739.29 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 850 | 489 | $388.52 |
| 84466 | 2,425 | 1,975 | $384.35 | |
| 82728 | 1,631 | 1,337 | $214.55 | |
| 0124A | 38 | 18 | $200.28 | |
| 82108 | 692 | 593 | $193.92 | |
| G0008 | Administration of influenza virus vaccine | 131 | 111 | $121.56 |
| 85041 | 3,102 | 2,351 | $113.41 | |
| 83540 | 1,783 | 1,445 | $112.87 | |
| A4657 | Syringe, with or without needle, each | 9,633 | 3,487 | $109.87 |
| 85048 | 3,053 | 2,310 | $91.95 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 130 | 96 | $56.08 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 824 | 95 | $8.74 |
| 82947 | 69 | 59 | $4.36 | |
| G0009 | Administration of pneumococcal vaccine | 15 | 13 | $0.00 |
| 83550 | 18 | 14 | $0.00 | |
| 90662 | 56 | 44 | $0.00 |